Table 5.
Baseline demographic characteristics for vaccination cohorts for analysis by ACIP guidelines.
| Demographic characteristic | Total | RV1 cohort | RV5 cohort | p-value RV1 vs. RV5 | Mixed cohort | No RV vaccine cohort | p-value RV1 vs. RV5 vs. Mixed vs. No RV vaccine cohort |
|---|---|---|---|---|---|---|---|
| n (row %) | 675,963 (100) | 48,724 (7.2) | 345,993 (51.2) | N/A | 18,192 (2.7) | 263,054 (38.9) | N/A |
| Birth year, n (row %/column %) | <0.001 | <0.001 | |||||
| 2008 | 90,234 (100 / 13.3) | 1,409 (1.6/2.9) | 50,766 (56.3 / 14.7) | 1,626 (1.8 / 8.9) | 36,433 (40.4 / 13.9) | ||
| 2009 | 171,319 (100 / 25.3) | 11,970 (7.0 / 24.6) | 87,677 (51.2 / 25.3) | 5,727 (3.3 / 31.5) | 65,945 (38.5 / 25.1) | ||
| 2010 | 189,234 (100 / 28.0) | 11,956 (6.3 / 24.5) | 93,872 (49.6 / 27.1) | 5,376 (2.8 / 29.6) | 78,030 (41.2 / 29.7) | ||
| 2011 | 168,376 (100 / 24.9) | 15,823 (9.4 / 32.5) | 81,828 (48.6 / 23.7) | 4,227 (2.5 / 23.2) | 66,498 (39.5 / 25.3) | ||
| 2012 | 48,198 (100 / 7.1) | 6,428 (13.3/13.2) | 27,769 (57.6 / 8.0) | 1,076 (2.2 / 5.9) | 12,925 (26.8 / 4.9) | ||
| 2013 | 8,602 (100 / 1.3) | 1,138 (13.2 / 2.3) | 4,081 (47.4 / 1.2) | 160 (1.9 / 0.9) | 3,223 (37.5 / 1.2) | ||
| Sex, n (row %/column %) | 0.4732 | <0.001 | |||||
| Male | 344,770 (100 / 51.0) | 24,631 (50.6) | 175,507 (50.9 / 50.7) | 9,310 (2.7 / 51.2) | 135,322 (39.2 / 51.4) | ||
| Female | 331,193 (100 / 49.0) | 24,093 (49.4) | 170,486 (51.5 / 49.3) | 8,882 (2.7 / 48.8) | 127,732 (38.6 / 48.6) | ||
| Race, n (row %/column %) | <0.001 | <0.001 | |||||
| White | 236,427 (100 / 35.0) | 20,409 (8.6 / 41.9) | 123,502 (52.2 / 35.7) | 7,581 (3.2 / 41.7) | 84,935 (35.9 / 32.3) | ||
| Black | 201,302 (100 / 29.8) | 13,869 (6.9 / 28.5) | 105,678 (52.5 / 30.5) | 5,181 (2.6 / 28.5) | 76,574 (38.0 / 29.1) | ||
| Hispanic1 | 122,919 (100 / 18.2) | 6,161 (5.0 / 12.6) | 59,145 (48.1 / 17.1) | 2,445 (2.0 / 13.4) | 55,168 (44.9 / 21.0) | ||
| Other/Unknown | 115,315 (100 / 17.1) | 8,285 (7.2 / 17.0) | 57,668 (50.0 / 16.7) | 2,985 (2.6 / 16.4) | 46,377 (40.2 / 17.6) | ||
| State, n (row %/column %) | <0.001 | <0.001 | |||||
| Florida | 376,172 (100 / 55.6) | 21,614 (5.7 / 44.4) | 163,650 (43.5 / 47.3) | 7,180 (1.9 / 39.5) | 183,728 (48.8 / 69.8) | ||
| Iowa | 80,893 (100 / 12.0) | 5,853 (7.2 / 12.0) | 44,214 (54.7 / 12.8) | 2,308 (2.9 / 12.7) | 28,518 (35.3 / 10.8) | ||
| Kansas | 74,024 (100 / 11.0) | 10,464 (14.1 / 21.5) | 39,661 (53.6 / 11.5) | 3,646 (4.9 / 20.0) | 20,253 (27.4 / 7.7) | ||
| Mississippi | 144,874 (100 / 21.4) | 10,793 (7.4 / 22.2) | 98,468 (68.0 / 28.5) | 5,058 (3.5 / 27.8) | 30,555 (21.1 / 11.6) | ||
| Health insurance type, n (row %/column %) | <0.001 | <0.001 | |||||
| FFS | 419,737 (100 / 62.1) | 28,861 (6.9 / 59.2) | 236,931 (56.4 / 68.5) | 13,200 (3.1 / 72.6) | 140,745 (33.5 / 53.3) | ||
| Other/Unknown | 256,226 (100 / 37.9) | 19,863 (7.8 / 40.8) | 109,062 (42.6 / 31.5) | 4,992 (1.9 / 27.4) | 122,309 (47.7 / 46.5) |
ACIP, Advisory Committee on Immunization Practices; RV1, Rotarix™, GSK Vaccines; RV5, RotaTeq, Merck & Co, Inc.; N/A; not applicable; FFS, Fee-for-service
1
Kansas claims data did not specifically identify Hispanic individuals.